Subscription

Iron Spark I Inc. Announces Closing of Over-Allotment Option

Retrieved on: 
Thursday, July 15, 2021

Iron Spark I Inc. (NASDAQ Capital Market: ISAA) ("Iron Spark" or the "Company"), a special purpose acquisition company, today announced the closing of the issuance of an additional 1,680,000 shares of Class A Common Stock (the Over-Allotment Option Shares) pursuant to the partial exercise of the underwriters over-allotment option in connection with the Companys initial public offering.

Key Points: 
  • Iron Spark I Inc. (NASDAQ Capital Market: ISAA) ("Iron Spark" or the "Company"), a special purpose acquisition company, today announced the closing of the issuance of an additional 1,680,000 shares of Class A Common Stock (the Over-Allotment Option Shares) pursuant to the partial exercise of the underwriters over-allotment option in connection with the Companys initial public offering.
  • Closing of the issuance of the Over-Allotment Option Shares occurred on June 16, 2021.
  • Morgan Stanley acted as sole book-running manager in the offering.
  • A registration statement relating to these securities was declared effective by the U.S. Securities and Exchange Commission (the SEC) on June 8, 2021.

Cullman Bancorp, Inc. Announces Expected Closing Date

Retrieved on: 
Monday, July 12, 2021

The closing of the Conversion and the related subscription offering is expected to occur at the close of business on July 14, 2021, subject to customary closing conditions.

Key Points: 
  • The closing of the Conversion and the related subscription offering is expected to occur at the close of business on July 14, 2021, subject to customary closing conditions.
  • A total of 4,284,375 shares of common stock are expected to be sold in the subscription offering at a price of $10.00 per share.
  • Approximately 7,406,000 shares of New Cullman common stock are expected to be outstanding after the completion of the offering and the exchange, before taking into account adjustments for fractional shares.
  • The Companys banking subsidiary, Cullman Savings Bank, opened in 1887 and currently operates three full-service offices in Cullman, Alabama and one full-service office in Hanceville, Alabama.

HUTCHMED Announces Full Exercise of the Over-allotment Option of the Global Offering

Retrieved on: 
Monday, July 12, 2021

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., July 12, 2021 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (HUTCHMED or the Company) (Nasdaq/AIM: HCM, HKEX:13) today announces the full exercise of the over-allotment option of the Global Offering.

Key Points: 
  • HONG KONG and SHANGHAI and FLORHAM PARK, N.J., July 12, 2021 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (HUTCHMED or the Company) (Nasdaq/AIM: HCM, HKEX:13) today announces the full exercise of the over-allotment option of the Global Offering.
  • Approval for the listing of and permission to deal in the Over-allotment Shares has already been granted by the Listing Committee of the Hong Kong Stock Exchange.
  • The gross proceeds to the Company from the Over-allotment Option, before deducting underwriting fees and the offering expenses, are expected to be approximately HK$625 million.
  • These forward-looking statements reflect HUTCHMEDs current expectations regarding future events, including statements about the Global Offering and listing, the use of proceeds and the Companys plans and objectives.

BioMind Research Corp and Crosswinds Holdings Inc. Announce Closing of Private Placement

Retrieved on: 
Friday, July 9, 2021

Toronto, Ontario--(Newsfile Corp. - July 9, 2021) - BioMind Research Corp ("Biomind" or the "Company") and Crosswinds Holdings Inc. ("Crosswinds") are pleased to announce the closing of the previously announced private placement (the "Financing") of subscription receipts (the "Subscription Receipts") of Biomind.

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - July 9, 2021) - BioMind Research Corp ("Biomind" or the "Company") and Crosswinds Holdings Inc. ("Crosswinds") are pleased to announce the closing of the previously announced private placement (the "Financing") of subscription receipts (the "Subscription Receipts") of Biomind.
  • References herein to the "Resulting Issuer" refer to Crosswinds following the completion of the Transaction.
  • Each Compensation Warrant is exercisable to acquire one Biomind Share at the Issue Price for a period of 24 months from closing of the Financing.
  • The common shares in the capital of Crosswinds (the "Crosswinds Shares") were de-listed from the Toronto Stock Exchange on March 28, 2019.

A.I.S. Resources Closes Oversubscribed Financing

Retrieved on: 
Friday, July 9, 2021

Resources Limited( TSXV: AIS, OTCQB: AISSF ) (the Company or AIS)announces the Company has closed its oversubscribed non-brokered private placement of 10,547,500 units (Units) at a price of $0.08 per unit for gross proceeds of $843,800 (the Private Placement).

Key Points: 
  • Resources Limited( TSXV: AIS, OTCQB: AISSF ) (the Company or AIS)announces the Company has closed its oversubscribed non-brokered private placement of 10,547,500 units (Units) at a price of $0.08 per unit for gross proceeds of $843,800 (the Private Placement).
  • Martyn Element, Chairman of the Board stated, We are pleased to close this oversubscribed placement.
  • The funds will enable us to aggressively pursue our exploration and development program on our highly prospective Australian gold properties.
  • In the next week the Company will provide an in-depth update of its Australian gold properties and its Argentinian lithium option agreement with Spey Resources.

TransCode Therapeutics, Inc. Announces Pricing of Initial Public Offering

Retrieved on: 
Thursday, July 8, 2021

TransCode Therapeutics, Inc. (Nasdaq: RNAZ), ("TransCode" or the "Company") an emerging RNA oncology company, created on the belief that cancer can be defeated through the intelligent design and effective delivery of RNA therapeutics, today announced the pricing of its initial public offering of 6,250,000 shares of its common stock at a public offering price of $4.00 per share, for gross proceeds of $25,000,000, before deducting underwriting discounts and offering expenses.

Key Points: 
  • TransCode Therapeutics, Inc. (Nasdaq: RNAZ), ("TransCode" or the "Company") an emerging RNA oncology company, created on the belief that cancer can be defeated through the intelligent design and effective delivery of RNA therapeutics, today announced the pricing of its initial public offering of 6,250,000 shares of its common stock at a public offering price of $4.00 per share, for gross proceeds of $25,000,000, before deducting underwriting discounts and offering expenses.
  • In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 937,500 shares of common stock to cover over-allotments at the initial public offering price, less the underwriting discount.
  • The offering is expected to close on July 13, 2021, subject to satisfaction of customary closing conditions.
  • ThinkEquity, a division of Fordham Financial Management, Inc., is acting as sole book-running manager for the offering.

Imperial Provides Additional Details Regarding Rights Offering

Retrieved on: 
Thursday, July 8, 2021

VANCOUVER, British Columbia, July 08, 2021 (GLOBE NEWSWIRE) -- Imperial Metals Corporation (the Company) (TSX:III) is providing additional details of the Rights Offering completed June 25, 2021.

Key Points: 
  • VANCOUVER, British Columbia, July 08, 2021 (GLOBE NEWSWIRE) -- Imperial Metals Corporation (the Company) (TSX:III) is providing additional details of the Rights Offering completed June 25, 2021.
  • To the knowledge of the Company, no person became an insider as a result of the Rights Offering.
  • Existing insiders acquired an aggregate of 5,834,477 shares pursuant to the Basic Subscription Privilege and 1,453,337 shares pursuant to the Additional Subscription Privilege.
  • Imperial is a Vancouver based exploration, mine development and operating company.

Oceanic Wind Energy Inc. Announces a Non-Brokered Private Placement

Retrieved on: 
Thursday, July 8, 2021

Each Unit shall consist of one common share in the capital of the Company (a Share) and one common share purchase warrant, a Warrant).

Key Points: 
  • Each Unit shall consist of one common share in the capital of the Company (a Share) and one common share purchase warrant, a Warrant).
  • If the Offering is oversubscribed and cannot be increased, subscriptions will be reduced on a pro-rata basis.
  • Subscription forms can be obtained by contacting the Company by telephone at 604-631-4483, or by email at [email protected].
  • Oceanic intends to use the net proceeds for general corporate purposes, working capital and to support Northland Power Inc. in their work to obtain a PPA for the offshore wind project in Hecate Strait.

The Alkaline Water Company Announces Closing of Non-Brokered Private Placement of Subscription Receipts

Retrieved on: 
Tuesday, July 6, 2021

The Alkaline Water Company Inc. (NASDAQ and CSE: WTER) (the Company) today announces, that further to its News Release of July 5, 2021, it has closed a non-brokered private placement financing (the Financing) of 4,757,381 subscription receipts (each, a Subscription Receipt) at a price of US$1.05 per Subscription Receipt for total gross proceeds of US $4,995,250.05.

Key Points: 
  • The Alkaline Water Company Inc. (NASDAQ and CSE: WTER) (the Company) today announces, that further to its News Release of July 5, 2021, it has closed a non-brokered private placement financing (the Financing) of 4,757,381 subscription receipts (each, a Subscription Receipt) at a price of US$1.05 per Subscription Receipt for total gross proceeds of US $4,995,250.05.
  • We really could not have found a better partner for Alkaline88 than Shaquille, said Ricky Wright, President and CEO of The Alkaline Water Company.
  • About The Alkaline Water Company:
    Founded in 2012, The Alkaline Water Company (NASDAQ and CSE: WTER) is headquartered in Scottsdale, Arizona.
  • Additionally, in 2020, the Company launched A88 Infused Beverage Division Inc., which includes the Companys CBD water and flavor-infused water.

DGAP-News: High interest in flatexDEGIRO placement, aiming for MDAX listing

Retrieved on: 
Friday, July 2, 2021

High interest in flatexDEGIRO placement, aiming for MDAX listing

Key Points: 
  • High interest in flatexDEGIRO placement, aiming for MDAX listing
    The issuer is solely responsible for the content of this announcement.
  • High interest in flatexDEGIRO placement, aiming for MDAX listing
    - Strong operational execution and solid development of the capital market strategy generates high interest of blue-chip investors in 5-times oversubscribed private placement at ca.
  • 4.5% discount
    Frankfurt/Main - Today, the DEGIRO founders and shareholders of flatexDEGIRO AG (WKN: FTG111, ISIN: DE000FTG1111, Ticker: FTK.GR) have sold 650,000 shares in a private placement.
  • During the recent weeks, flatexDEGIRO, Europe's largest and fastest-growing retail online broker, has received a high number of inquiries from global blue-chip institutional investor.